IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Euclidean Capital LLC

Q3 2023 Holdings

Filed 2023-11-14 | 13 holdings | $458.4M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2023-12-01) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Spdr Gold TR(GLD)GOLD SHS78463V107$182.2M1,062,50039.7%
Ishares TR(INDA)MSCI INDIA ETF46429B598$107.2M2,425,14423.4%
Spdr S&P 500 ETF TR(SPY)TR UNIT78462F103$105.3M246,25023.0%
PMV Pharmaceuticals Inc(PMVP)COM69353Y103$16.1M2,627,6433.5%
Rapt Therapeutics Inc(RAPTEUR)COM75382E109$10.9M657,8992.4%
23Andme Holding CoCLASS A COM90138Q108$10.0M10,243,1222.2%
Alector Inc(ALEC)COM014442107$8.5M1,307,8581.8%
Foghorn Therapeutics Inc(FHTX)COM344174107$7.9M1,573,7611.7%
Oric Pharmaceuticals Inc(ORIC)COM68622P109$6.0M989,4101.3%
Tenaya Therapeutics Inc(TNYA)COM87990A106$2.6M1,015,7050.6%
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$1.1M992,1680.2%
Surrozen IncACOM86889P109$644.6K1,315,4630.1%
Surrozen Inc(SRZNW)A*W EXP 08/01/20386889P117$7.0K170,8330.0%